Ocular Therapeutix Inc (OCUL)
6.18
-0.09
(-1.44%)
USD |
NASDAQ |
May 17, 16:00
6.18
0.00 (0.00%)
After-Hours: 20:00
Ocular Therapeutix Free Cash Flow: -87.11M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -87.11M |
December 31, 2023 | -76.32M |
September 30, 2023 | -72.52M |
June 30, 2023 | -78.49M |
March 31, 2023 | -67.79M |
December 31, 2022 | -63.32M |
September 30, 2022 | -59.99M |
June 30, 2022 | -59.29M |
March 31, 2022 | -68.10M |
December 31, 2021 | -66.74M |
September 30, 2021 | -57.46M |
June 30, 2021 | -58.07M |
March 31, 2021 | -52.81M |
December 31, 2020 | -54.40M |
September 30, 2020 | -67.96M |
June 30, 2020 | -74.06M |
March 31, 2020 | -78.81M |
December 31, 2019 | -79.82M |
September 30, 2019 | -73.88M |
June 30, 2019 | -65.26M |
March 31, 2019 | -58.37M |
Date | Value |
---|---|
December 31, 2018 | -51.12M |
September 30, 2018 | -47.94M |
June 30, 2018 | -53.01M |
March 31, 2018 | -55.35M |
December 31, 2017 | -58.72M |
September 30, 2017 | -56.07M |
June 30, 2017 | -47.85M |
March 31, 2017 | -42.77M |
December 31, 2016 | -35.92M |
September 30, 2016 | -36.74M |
June 30, 2016 | -38.31M |
March 31, 2016 | -37.67M |
December 31, 2015 | -35.52M |
September 30, 2015 | -32.48M |
June 30, 2015 | -29.31M |
March 31, 2015 | -24.67M |
December 31, 2014 | -21.76M |
September 30, 2014 | -19.35M |
June 30, 2014 | -15.70M |
March 31, 2014 | -13.96M |
December 31, 2013 | -13.03M |
Free Cash Flow Range, Past 5 Years
-87.11M
Minimum
Mar 2024
-52.81M
Maximum
Mar 2021
-68.11M
Average
-67.88M
Median
Free Cash Flow Benchmarks
Amgen Inc | 7.098B |
Assertio Holdings Inc | 34.40M |
CytomX Therapeutics Inc | -92.34M |
EyePoint Pharmaceuticals Inc | -16.65M |
Cormedix Inc | -45.70M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -33.89M |
Cash from Investing (Quarterly) | -0.255M |
Cash from Financing (Quarterly) | 321.22M |
Free Cash Flow Per Share (Quarterly) | -0.2586 |
Free Cash Flow to Equity (Quarterly) | -25.67M |
Free Cash Flow Yield | -14.65% |